NCT06823037 Hormonal Contraception Access Through Pharmacist Prescribing Implementation
| NCT ID | NCT06823037 |
| Status | Recruiting |
| Phase | — |
| Sponsor | EMPOWERX INC |
| Condition | Contraception |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2025-10-09 |
| Primary Completion | 2026-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2025-10-09 with a primary completion date of 2026-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if use of the HAPPI software can improve pharmacist-provided birth control services. The main questions it aims to answer are: 1. Does the HAPPI software make it easier for pharmacists to provide birth control services in their pharmacy? 2. Does the HAPPI software make it easier for patients to access birth control? Researchers will compare pharmacists' implementation and patients' access when using the HAPPI software and when not using the HAPPI software to see if the software improves implementation and access. Participants will include pharmacists and patients. Pharmacists will be asked to provide birth control services as normal while using the HAPPI software. Patients will be asked to receive birth control services from a pharmacist as normal, while using the HAPPI software.
Eligibility Criteria
PHARMACIST Participants Inclusion Criteria: * 18 years of age or older * Provide birth control services in a participating pharmacy * Use the HAPPI software to provide birth control services Exclusion Criteria: * None PATIENT Participants Inclusion Criteria: * 18 years of age or older * Seek birth control services at a participating pharmacy * Use the HAPPI software to receive birth control services at a participating pharmacy Exclusion Criteria: * NONE
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06823037 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Contraception. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06823037 currently recruiting?
Yes, NCT06823037 is actively recruiting participants. Contact the research team at jenny@birthcontrolpharmacist.com for enrollment information.
Where is the NCT06823037 trial being conducted?
This trial is being conducted at Del Mar, United States.
Who is sponsoring the NCT06823037 clinical trial?
NCT06823037 is sponsored by EMPOWERX INC. The trial plans to enroll 150 participants.